Professor Paul Harkin is Founder and President of Almac Diagnostic Services. In 2004 Almac Diagnostic Services was incorporated as a Division of the Almac Group and Professor Harkin was appointed as President and Managing Director with overall responsibility for the strategic, financial and operational leadership of the company.
Read MorePaul is also a Professor in Molecular Oncology within the Centre for Cancer Research and Cell Biology at Queen’s University Belfast where his research has focused on the role played by BRCA1 mutation in the development of hereditary breast cancer. Prior to this appointment he had been a Research Fellow in Medicine at Harvard Medical School and the Massachusetts General Hospital where he developed his interest in the emerging field of precision medicine.